Merrimack Pharmaceuticals Inc (MACK)
5.18
-0.03 -0.58%
NASDAQ
Aug 5, 14:50
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.31 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -3.973M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0% |
| Price and Valuation | |
| Market Cap | 69.46M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 69330.42 |
| PE Ratio | -- |
| Price to Book Value | 4.408 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | -- |
| Free Cash Flow (Quarterly) | -0.437M |
| Return on Equity | Upgrade |
View All MACK News
News
-
WireHeadlineTime (ET)
-
Yahoo06/08 05:31
-
Yahoo06/07 14:10
-
Globe Newswire05/28 08:00
-
SA Breaking News03/10 18:10
-
Yahoo03/10 18:00
-
SA Breaking News02/18 17:46
-
SA Breaking News02/18 08:26
-
Yahoo12/10 02:10
-
SA Breaking News12/04 11:07
-
SA Breaking News12/03 11:10
-
SA Breaking News12/03 08:25
-
Yahoo12/03 07:46
-
SA Breaking News12/02 17:48
-
SA Breaking News12/02 12:41
-
SA Breaking News12/02 12:34
-
Yahoo11/29 12:12
-
SA Breaking News11/05 08:25
-
Yahoo11/05 08:20
-
SA Breaking News08/14 12:46
-
SA Breaking News08/07 08:29
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 08/06/2021 | Earnings Results | Q2 2021 Earnings Results |
| 06/10/2021 10:00 EST | AGM | 2020 Annual General Meeting |
| 05/06/2021 | Earnings Results | Q1 2021 Earnings Results |
| 03/10/2021 | Earnings Results | Q4 2020 Earnings Results |
| 11/05/2020 | Earnings Results | Q3 2020 Earnings Results |
| 08/07/2020 | Earnings Results | Q2 2020 Earnings Results |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- Description: Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
- URL: http://www.merrimack.com
- Investor Relations URL: http://investors.merrimackpharma.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: Aug. 06, 2021
- Last Earnings Release: May. 06, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Dec. 13, 2019
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 5.18 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MACK Tweets Stocktwits
Advertisement
